KFDA notifies 182 substitutive drugs to KPA.

Published: 2006-05-01 06:55:00

Updated: 2006-05-01 06:55:00

9 products including Alend 70mg tab. were earlier suspended to reimburse by the NHI scheme due to the bio equivalency test fabrication, for which, instead, the KFDA sent an official notification to the Korea Pharmaceutical Association (KPA) about 182 substitutive drugs.

The substitutive drugs ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK